Bristol-Myers Squibb Co. (BMY) PT Raised to $60 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $64.80 +0.95%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Citi analyst Geoff Meacham raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $53.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Arm Holdings (ARM) PT Lowered to $250 at TD Cowen
- Hut 8 Mining Corp. (HUT) PT Lowered to $127 at Cantor Fitzgerald
- Acadia Pharmaceuticals (ACAD) PT Raised to $38 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
